CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Womens Health Startups (476) Pharma Startups (6570)
Celmatix is developing diagnostic tools to improve reproductive health outcomes for female infertility. By partnering with fertility clinics and other stakeholders, the company is making better use of electronic medical data. Celmatix's offerings hel...Show all
Company (Alive / Active)
Phone: 646-389-0245
14 Wall Street
Suite 16D
New York, 10005
New York, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Name | Firm |
|---|---|
| Login to see details | Topspin Partners |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Methods and devices for assessing risk of female infertility | Jan 26, 2015 | Dec 05, 2017 | Patent |
| Systems and methods for determining the probability of a pregnancy at a selected point in time | Oct 17, 2012 | Nov 03, 2015 | Patent |
| Methods and systems for assessing fertility based on subclinical genetic factors | Oct 09, 2017 | Application | |
| Method for assessing fertility based on male and female genetic and phenotypic data | May 31, 2017 | Application | |
| Methods and systems for assessing infertility and ovulatory function disorders | Mar 09, 2017 | Application |
